HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 81 filers reported holding HARVARD BIOSCIENCE INC in Q3 2013. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $211,000 | +61.1% | 33,916 | +83.2% | 0.00% | – |
| Q4 2021 | $131,000 | -29.2% | 18,516 | -30.0% | 0.00% | – |
| Q3 2021 | $185,000 | -86.3% | 26,465 | -83.7% | 0.00% | -100.0% |
| Q2 2021 | $1,351,000 | +1610.1% | 162,134 | +1019.8% | 0.00% | – |
| Q1 2021 | $79,000 | +16.2% | 14,479 | -8.4% | 0.00% | – |
| Q4 2020 | $68,000 | +23.6% | 15,811 | +23.5% | 0.00% | – |
| Q1 2019 | $55,000 | -11.3% | 12,801 | -21.8% | 0.00% | – |
| Q3 2015 | $62,000 | -68.4% | 16,364 | -65.9% | 0.00% | – |
| Q3 2014 | $196,000 | -10.5% | 47,988 | -0.1% | 0.00% | – |
| Q2 2014 | $219,000 | -4.8% | 48,060 | -1.0% | 0.00% | -100.0% |
| Q1 2014 | $230,000 | -2.5% | 48,549 | -3.5% | 0.00% | 0.0% |
| Q4 2013 | $236,000 | +105.2% | 50,317 | +130.5% | 0.00% | – |
| Q3 2013 | $115,000 | +66.7% | 21,833 | +48.9% | 0.00% | – |
| Q2 2013 | $69,000 | – | 14,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
| 272 Capital LP | 3,062,963 | $16,815,667 | 6.18% |
| Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
| Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
| BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
| Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
| Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
| Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
| HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |